De Burlo Group Inc Novo Nordisk A S Transaction History
De Burlo Group Inc
- $736 Million
- Q1 2024
A detailed history of De Burlo Group Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, De Burlo Group Inc holds 123,016 shares of NVO stock, worth $17.5 Million. This represents 2.15% of its overall portfolio holdings.
Number of Shares
123,016Holding current value
$17.5 Million% of portfolio
2.15%Shares
3 transactions
Others Institutions Holding NVO
# of Institutions
1,861Shares Held
310MCall Options Held
5.29MPut Options Held
4.93M-
Jennison Associates LLC21.1MShares$3 Billion1.82% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.7MShares$1.95 Billion0.83% of portfolio
-
Bank Of America Corp Charlotte, NC13.1MShares$1.86 Billion0.16% of portfolio
-
Morgan Stanley New York, NY12MShares$1.71 Billion0.13% of portfolio
-
Fayez Sarofim & CO Houston, TX11.8MShares$1.68 Billion4.6% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $321B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...